Showing results (281-290 of 550) with videos related to

Sort By:
Pageof 55
European Heart Journal|August 30, 2005
Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteriesWillem Drenthen, Petronella G Pieper, Martine Ploeg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2005
MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticleWillem J M Mulder, Gustav J Strijkers, Jo W Habets, et al.
Heart (British Cardiac Society)|July 16, 2015
Individualised prediction of pulmonary homograft durability in tetralogy of FallotJouke P Bokma, Michiel M Winter, Thomas Oosterhof, et al.
International Journal of Cardiology|June 12, 2017
Clinical course of tricuspid regurgitation in repaired tetralogy of FallotO I Woudstra, J P Bokma, M M Winter, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 9, 2011
Bicuspid stenotic aortic valves: clinical characteristics and morphological assessment using MRI and echocardiographyI C Joziasse, A Vink, M J Cramer, et al.
Circulation|September 20, 2012
Sudden cardiac death in adult congenital heart diseaseZeliha Koyak, Louise Harris, Joris R de Groot, et al.
Contrast Media & Molecular Imaging|October 23, 2010
Influence of cell-internalization on relaxometric, optical and compositional properties of targeted paramagnetic quantum dot micellesL W E Starmans, M B Kok, H M H F Sanders, et al.
International Journal of Cardiology|December 19, 2017
Incidence and risk factors of post-operative arrhythmias and sudden cardiac death after atrioventricular septal defect (AVSD) correction: Up to 47years of follow-upRohit K Kharbanda, Nico A Blom, Mark G Hazekamp, et al.
Contemporary Clinical Trials|April 30, 2011
Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?Mark J Schuuring, Jeroen C Vis, Berto J Bouma, et al.
International Journal of Cardiology|June 27, 2008
Down patients with Eisenmenger syndrome: is bosentan treatment an option?Mariëlle G J Duffels, Jeroen C Vis, Rosa L E van Loon, et al.
Pageof 55